Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
12:00 AM - DEVICE TALKS
9
11
12
13
14
16
18
19
20
21
22
23
24
26
27
28
29
30
31
1
2
3
4
DEVICE TALKS
DEVICE TALKS BOSTON 2018: BIGGER AND BETTER THAN EVER! Join us Oct. 8-10 for the 7th annual DeviceTalks Boston, back in the city where it [...]
6th Annual HealthIMPACT Midwest
2018-10-10    
All Day
REV1 VENTURES COLUMBUS, OH The Provider-Patient Experience Summit - Disrupting Delivery without Disrupting Care HealthIMPACT Midwest is focused on technologies impacting clinician satisfaction and performance. [...]
15 Oct
2018-10-15 - 2018-10-16    
All Day
Conference Series Ltd invites all the participants from all over the world to attend “3rd International Conference on Environmental Health” during October 15-16, 2018 in Warsaw, Poland which includes prompt keynote [...]
17 Oct
2018-10-17 - 2018-10-19    
7:00 am - 6:00 pm
BALANCING TECHNOLOGY AND THE HUMAN ELEMENT In an era when digital technologies enable individuals to track health statistics such as daily activity and vital signs, [...]
Epigenetics Congress 2018
2018-10-25 - 2018-10-26    
All Day
Conference: 5th World Congress on Epigenetics and Chromosome Date: October 25-26, 2018 Place: Istanbul, Turkey Email: epigeneticscongress@gmail.com About Conference: Epigenetics congress 2018 invites all the [...]
Events on 2018-10-08
DEVICE TALKS
8 Oct 18
425 Summer Street
Events on 2018-10-10
Events on 2018-10-17
17 Oct
Events on 2018-10-25
Epigenetics Congress 2018
25 Oct 18
Istanbul
Latest News

CVS Health Applauds FDA’s Steps to Address the Epidemic of Youth Use of Electronic Cigarettes and Vaping Devices

As the nation’s first and only national pharmacy chain to have eliminated the sale of cigarettes and other harmful tobacco products from its retail stores and having never sold e-cigarettes and vaping devices CVS Health (NYSE: CVS) today applauded the enforcement actions taken by the U.S. Food and Drug Administration (FDA) to curtail the sale and marketing of e-cigarettes to the nation’s youth.

“We applaud the historic enforcement actions announced today by FDA Commissioner Dr. Scott Gottlieb, and believe they represent the most important step the agency has taken to date to curtail youth use of e-cigarettes and flavored nicotine products,” said Troyen Brennan, M.D., M.P.H. and Chief Medical Officer for CVS Health. “We hope the actions taken today by the FDA will reduce the number of people that are exposed to tobacco and other harmful products, which can reduce the prevalence of tobacco-related diseases including lung cancer, heart disease and stroke and make a significant impact on the health of our next generation.”

In 2014, CVS Health announced its decision to stop selling cigarettes in all CVS Pharmacy stores, making the company the first national pharmacy chain to take this step in support of the health of its patients and customers. In the eight months following the company’s exit from tobacco, smokers in states where CVS Pharmacy had a 15 percent or greater share of the retail pharmacy market purchased 95 million fewer packs of cigarettes. The company also saw a four percent increase in nicotine patch purchases in the states with a CVS Pharmacy market share of 15 percent or more, in the period immediately following the end of tobacco sales. Most recently, findings showing that customers who had purchased cigarettes exclusively at CVS Pharmacy were 38 percent more likely to stop buying, and presumably stop using, cigarettes altogether were published in the American Journal of Public Health. This research confirmed that the company’s decision had a powerful public health impact by disrupting access to cigarettes and helping more of our customers on their path to better health.

Recognizing the impact it could have on reducing smoking and tobacco use in the country, CVS Health followed up its actions with BE THE FIRST, a five-year $50 million initiative to help deliver the nation’s first tobacco-free generation. Since it was introduced, BE THE FIRST has delivered meaningful support to the country’s ongoing efforts to prevent smoking and nicotine addiction among youth which is critical to ending tobacco use in the United States. By funding programs with the nation’s leading tobacco control advocates, including the American Cancer Society, American Lung Association, Campaign for Tobacco Free Kids, CATCH Global Foundation and Truth Initiative, CVS Health and the CVS Health Foundation has helped reach more than 4 million young people with effective anti-smoking education and healthy behavior programming and is helping 146 colleges and universities advocate for, adopt and implement tobacco-free campus policies.

“We’re encouraged by our contributions to a continuing decline in youth smoking rates, however far too many young people are still using a variety of harmful tobacco and nicotine products, such as e-cigarettes and vapes, that facilitate initiation of tobacco use,” added Brennan.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,800 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 94 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

SOURCE CVS Health